Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up
Crossref DOI link: https://doi.org/10.1007/s00520-015-2915-2
Published Online: 2015-08-23
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Majithia, Neil
Atherton, Pamela J.
Lafky, Jacqueline M.
Wagner-Johnston, Nina
Olson, Janet
Dakhil, Shaker R.
Perez, Edith A.
Loprinzi, Charles L.
Hines, Stephanie L.
Text and Data Mining valid from 2015-08-23